16156-Lung Cancer-NSCLC-517

Lung Cancer

CA209-817: A Phase IIIb/IV Safety and Efficacy Trial of Flat Dose Nivolumab in Combination with Ipilimumab in Participants with Non-Small Cell Lung Cancer

  • Details

ClinicalTrials.gov ID: NCT02869789
Diagnosis Type: NSCLC
USOR Number: 16156

  • Address

3700 W State Route 89A
Sedona, AZ 86336
P: (928) 204-4163

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.